Fatty acid translocase CD36 (CD36) plays an important role in the initiation and pathogenesis of chronic liver disease and non-alcoholic fatty liver disease (NAFLD). This evidence concerns the gene CD36 and metabolic dysfunction-associated steatotic liver disease.